Clinical Trial Update: Changes in Prostate Specific Antigen Levels During Synergo Therapy-Intravesical Chemotherapy Instillations Combined With Hyperthermia

View source ↗

Summary

An update on changes in prostate-specific antigen (PSA) levels observed during Synergo intravesical chemotherapy with hyperthermia for bladder cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer

Drugs mentioned

• Mitomycin-C (mitomycin C)

Snippet

Sponsor: HaEmek Medical Center, Israel | Conditions: Bladder Cancer | Status: UNKNOWN